Status: retired, Primitive. Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3769589014 | Product containing precisely tesamorelin (as tesamorelin acetate) 1 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3769590017 | Tesamorelin (as tesamorelin acetate) 1 mg lyophilized powder for solution for injection vial | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3786511010 | Tesamorelin (as tesamorelin acetate) 1 mg lyophilised powder for solution for injection vial | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tesamorelin (as tesamorelin acetate) 1 mg lyophilised powder for solution for injection vial | Has unit of presentation | Vial | false | Inferred relationship | Some | ||
| Tesamorelin (as tesamorelin acetate) 1 mg lyophilised powder for solution for injection vial | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Tesamorelin (as tesamorelin acetate) 1 mg lyophilised powder for solution for injection vial | Has presentation strength denominator unit | Vial | false | Inferred relationship | Some | 1 | |
| Tesamorelin (as tesamorelin acetate) 1 mg lyophilised powder for solution for injection vial | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Tesamorelin (as tesamorelin acetate) 1 mg lyophilised powder for solution for injection vial | Has presentation strength numerator value | 1 | false | Inferred relationship | Some | 1 | |
| Tesamorelin (as tesamorelin acetate) 1 mg lyophilised powder for solution for injection vial | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
| Tesamorelin (as tesamorelin acetate) 1 mg lyophilised powder for solution for injection vial | Has precise active ingredient | Tesamorelin acetate | false | Inferred relationship | Some | 1 | |
| Tesamorelin (as tesamorelin acetate) 1 mg lyophilised powder for solution for injection vial | Has BoSS | Tesamorelin | false | Inferred relationship | Some | 1 | |
| Tesamorelin (as tesamorelin acetate) 1 mg lyophilised powder for solution for injection vial | Is a | Tesamorelin only product in parenteral dose form | false | Inferred relationship | Some | ||
| Tesamorelin (as tesamorelin acetate) 1 mg lyophilised powder for solution for injection vial | Is a | Hypothalamic/pituitary hormone | false | Inferred relationship | Some | ||
| Tesamorelin (as tesamorelin acetate) 1 mg lyophilised powder for solution for injection vial | Is a | Product manufactured as parenteral dose form | false | Inferred relationship | Some | ||
| Tesamorelin (as tesamorelin acetate) 1 mg lyophilised powder for solution for injection vial | Has active ingredient | Tesamorelin | false | Inferred relationship | Some | ||
| Tesamorelin (as tesamorelin acetate) 1 mg lyophilised powder for solution for injection vial | Has manufactured dose form | Lyophilised powder for solution for injection | false | Inferred relationship | Some | ||
| Tesamorelin (as tesamorelin acetate) 1 mg lyophilised powder for solution for injection vial | Is a | Tesamorelin-containing product in parenteral dose form | false | Inferred relationship | Some | ||
| Tesamorelin (as tesamorelin acetate) 1 mg lyophilised powder for solution for injection vial | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
Description inactivation indicator reference set
REPLACED BY association reference set
FHIR